Latest Insider Transactions at Oak Street Health, Inc. (OSH)
This section provides a real-time view of insider transactions for Oak Street Health, Inc. (OSH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oak Street Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oak Street Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-0.41%
|
$1,350,000
$60.93 P/Share
|
|
Jun 22
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.88%
|
$2,950,000
$59.42 P/Share
|
|
Jun 17
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.38%
|
$330,512
$56.48 P/Share
|
|
Jun 16
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Bona fide gift
|
Direct |
21,100
-0.55%
|
-
|
|
Jun 16
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
17,600
-0.22%
|
-
|
|
Jun 15
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
109,400
-0.62%
|
$6,126,400
$56.14 P/Share
|
|
Jun 08
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.43%
|
$1,450,000
$58.79 P/Share
|
|
Jun 03
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.28%
|
$354,120
$60.06 P/Share
|
|
Jun 01
2021
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.81%
|
$600,000
$60.86 P/Share
|
|
Jun 01
2021
|
Newlight Partners LP Director |
SELL
Open market or private sale
|
Indirect |
4,791,569
-10.58%
|
$297,077,278
$62.0 P/Share
|
|
Jun 01
2021
|
General Atlantic LLC Director |
SELL
Open market or private sale
|
Indirect |
7,260,689
-10.58%
|
$435,641,340
$60.14 P/Share
|
|
May 27
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-0.27%
|
$1,350,000
$60.82 P/Share
|
|
May 25
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.22%
|
$1,550,000
$62.88 P/Share
|
|
May 21
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
22,410
-0.76%
|
$1,411,830
$63.61 P/Share
|
|
May 20
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.22%
|
$365,924
$62.17 P/Share
|
|
May 20
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
65,478
-2.18%
|
$4,125,114
$63.19 P/Share
|
|
May 13
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
109,400
-0.31%
|
$6,126,400
$56.1 P/Share
|
|
May 11
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.21%
|
$1,350,000
$54.39 P/Share
|
|
May 06
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.22%
|
$330,512
$56.42 P/Share
|
|
May 05
2021
|
Kim Keck Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+48.28%
|
-
|
|
May 04
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.15%
|
$2,950,000
$59.49 P/Share
|
|
May 03
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
12,112
-0.4%
|
$763,056
$63.27 P/Share
|
|
Apr 30
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
65,332
-2.11%
|
$3,919,920
$60.95 P/Share
|
|
Apr 29
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-0.79%
|
$1,372,500
$61.54 P/Share
|
|
Apr 29
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
125,068
-3.88%
|
$7,629,148
$61.72 P/Share
|
|
Apr 28
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
109,600
-2.31%
|
$6,795,200
$62.34 P/Share
|
|
Apr 27
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
125,000
-1.21%
|
$7,625,000
$61.35 P/Share
|
|
Apr 22
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.27%
|
$348,218
$59.97 P/Share
|
|
Apr 22
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
27,974
-0.34%
|
$1,650,466
$59.98 P/Share
|
|
Apr 21
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,026
-0.15%
|
$709,534
$59.95 P/Share
|
|
Apr 20
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.3%
|
$2,900,000
$58.71 P/Share
|
|
Apr 15
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
109,400
-0.6%
|
$6,235,800
$57.81 P/Share
|
|
Apr 15
2021
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.53%
|
$570,000
$57.87 P/Share
|
|
Apr 12
2021
|
Timothy M Cook Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,770
+1.16%
|
-
|
|
Apr 12
2021
|
Brian Clem Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,416
+2.09%
|
-
|
|
Apr 12
2021
|
Robert Guenthner Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,708
+1.21%
|
-
|
|
Apr 08
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.18%
|
$365,924
$62.14 P/Share
|
|
Mar 25
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.18%
|
$324,610
$55.1 P/Share
|
|
Mar 18
2021
|
Brian Clem Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
10,000
-1.6%
|
-
|
|
Mar 11
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.18%
|
$324,610
$55.4 P/Share
|
|
Feb 25
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.26%
|
$330,512
$56.06 P/Share
|
|
Feb 16
2021
|
Newlight Partners LP Director |
SELL
Open market or private sale
|
Indirect |
4,902,941
-9.77%
|
$274,564,696
$56.0 P/Share
|
|
Feb 16
2021
|
General Atlantic LLC Director |
SELL
Open market or private sale
|
Indirect |
7,429,453
-9.77%
|
$401,190,462
$54.18 P/Share
|
|
Feb 11
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,452
-0.26%
|
$847,476
$63.25 P/Share
|
|
Dec 07
2020
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
100,000
-13.8%
|
$4,600,000
$46.0 P/Share
|
|
Dec 07
2020
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
100,000
-6.63%
|
$4,600,000
$46.0 P/Share
|
|
Dec 07
2020
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
459,750
-7.0%
|
$21,148,500
$46.0 P/Share
|
|
Dec 07
2020
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
469,750
-5.89%
|
$21,608,500
$46.0 P/Share
|
|
Dec 07
2020
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
444,750
-4.97%
|
$20,458,500
$46.0 P/Share
|
|
Dec 04
2020
|
Mohit Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
219
+0.11%
|
$4,599
$21.0 P/Share
|